Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

 91.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 93.30
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 966.40m
  • Volume: 0
  • Market Cap: £881.36m
  • Beta: 0.03

Latest Deals

Traded Action Notifier PriceAmountValue
11-Sep-25 Buy Giles Wilson 89.85p 167 £150.05
11-Sep-25 Transfer From Giles Wilson 0.000p 167 £0.00
11-Sep-25 Transfer From Ije Nwokori 0.000p 167 £0.00
11-Sep-25 Buy Ije Nwokori 89.85p 167 £150.05
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69
11-Sep-25 Buy Ije Nwokori 89.85p 167 £150.05

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £7,182,000
Giles Wilson 230,694 £210,393
Robyn Perriss 94,328 £86,027
Andrew Harrison 76,594 £69,854
Lynne Weedall 40,054 £36,529
Ian Rogers 20,270 £18,486
Ije Nwokori 6,893 £6,286

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £337,387,505
IngreGrsy Limited 369,942,440 £337,387,505
Permira Holdings Limited 364,142,440 £332,097,905
Artemis Investment Management LLP 97,770,872 £89,167,035
Fidelity Management & Research 32,500,000 £29,640,000
Intertrust Employee Benefit Trustee Limited 135,000 £123,120

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 91.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 93.30
52 Week Low 47.52
Volume 0
Shares Issued 966.40m
Market Cap £881.36m
Beta 0.03

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page